FROM Paul Howard
Does Obamacare have a future after all? For six years, Republicans in Congress have voted to repeal and replace the Affordable Care Act, long dubbed "Obamacare." Now, with majorities in both Houses and Donald Trump in the White House, the process is beginning today. But in both houses, the GOP is divided. One side worries that supporters of President Trump may be among the millions who lose health insurance. The other says the new plan doesn't go far enough and complain its toughest provisions won’t take effect until 2020. They call it "Obamacare Light." Nobody knows the possible cost yet — and, as we hear, politics will be more important than substance.
America's Wild West of Drug Pricing Earlier this year, when pharma exec Martin Shkreli bought the rights to an old drug and then raised its price 5000%, Americans named him the most hated man in the country. But he is only doing what Big Pharma does everyday thanks to patent laws and America's free market approach to drug pricing. Rising costs are outraging patients, doctors and health insurers all along the political spectrum, but with all the money Big Pharma spends on lobbying, will Washington take up drug pricing reform?
Why Don't Facts Matter? "Fake News" may have a long history, but social media and 21st Century politics have brought it front and center. One reason for its appeal and its power is the tendency of so many people to cling to their beliefs — even when confronted with contradictory evidence. Today, another look at the Emotional States of America.
100 days of executive action: Accomplishment or posturing? President Trump's first 100 days have featured a flood of high-profile executive orders. Which ones do what he says they do, and which ones don't? How are Trump voters feeling now?
Will the march for science politicize objective research? Protesters are gathering all over the country for tomorrow's Earth Day March for Science. Since President Trump has proposed massive cuts in basic scientific research, will the movement be perceived as partisan politics — whether scientists themselves like it or not?